Log In
Print this Print this

HIVCide (formerly HivCide-I)

  Manage Alerts
Collapse Summary General Information
Company NanoViricides Inc.
DescriptionNanoviricide targeting HIV gp120
Molecular Target HIV gp120
Mechanism of ActionAntiviral agent
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today